Anbio Biotechnology Class A had a revenue of 2.53M in the quarter ending Dec 31, 2024, with -60.01%. This bring the company's revenue in the last twelve months to 8.85M, Increased -13.85%. In the fiscal year ending Dec 31, 2024, Anbio Biotechnology Class A had annual revenue of 8.19M with 21.95% growth.